Model.
Discover.
Develop.
Transforming the treatment of fibrotic disease through innovative drug discovery and development.
Advancing Preclinical Drug Development
Transforming Therapeutic Development
We advance preclinical drug development by integrating human induced pluripotent stem cells with multiple read-outs including biosensor technologies, harnessing translatable solutions for drug discovery.
Our state-of-the-art laboratory is located in the Technoparc Montréal, fostering innovation within a vibrant biotech community.
We screen our own compounds in our iPSC-based disease models.
Our Drug Discovery Program
Our Team
Meet the Crew
.jpg)
Our dedicated scientists and professionals are at the forefront of preclinical drug development and are committed to finding treatments for fibrotic diseases such as cardiac fibrosis.